These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34123571)

  • 1. The Effectiveness and Tolerability of Preformed Growth Factors Vehiculated Through Iontophoresis on Patients with Androgenetic Alopecia and Telogen Effluvium: A Clinical Study.
    Alessandrini AM; Bruni F; Piraccini BM; Starace M
    Dermatol Pract Concept; 2021 May; 11(3):e2021082. PubMed ID: 34123571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of the use of scalp microneedling in different types of alopecia.
    Starace M; Alessandrini A; Brandi N; Piraccini BM
    J Cosmet Dermatol; 2020 Mar; 19(3):646-650. PubMed ID: 31254437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium.
    Feldman PR; Feldman OJ; Guevara-Aguirre J; Fiebig KM
    Front Med (Lausanne); 2022; 9():918058. PubMed ID: 36045927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral minoxidil use in androgenetic alopecia and telogen effluvium.
    Feaster B; Onamusi T; Cooley JE; McMichael AJ
    Arch Dermatol Res; 2023 Mar; 315(2):201-205. PubMed ID: 35244759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.
    Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J
    EClinicalMedicine; 2021 Jul; 37():100978. PubMed ID: 34235415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia.
    Cedirian S; Bruni F; Quadrelli F; Caro G; Fortuna M; Rossi A; Piraccini BM; Starace M
    J Cosmet Dermatol; 2023 Dec; 22(12):3347-3351. PubMed ID: 37415302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium.
    Piccolo D; Crisman G; Conforti C; Buzzi M; Genovesi C; Marchi D; Mazzaracchio D; Goldust M
    Dermatol Ther; 2021 Mar; 34(2):e14799. PubMed ID: 33486860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.
    Evron E; Juhasz M; Babadjouni A; Mesinkovska NA
    Skin Appendage Disord; 2020 Nov; 6(6):329-337. PubMed ID: 33313047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
    Pekmezci E; Dündar C; Türkoğlu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Jun; 27(2):51-57. PubMed ID: 29945259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse hair loss in women].
    Trüeb RM
    Ther Umsch; 2002 May; 59(5):217-22. PubMed ID: 12090117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Dermoscopic Findings in Female Androgenetic Alopecia and Telogen Effluvium and Female Controls in a Tertiary Care Center.
    Bains P; Kaur S; Kaur K
    J Clin Aesthet Dermatol; 2022 May; 15(5):29-34. PubMed ID: 35642228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.
    Torres F; Tosti A
    Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonscarring scalp alopecia: Which laboratory analysis should we perform on whom?
    Öner Ü; Akdeniz N
    Turk J Med Sci; 2022 Feb; 52(1):188-194. PubMed ID: 34688244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.